FDA Sets New Decision Date For Eliquis (Apixaban)
The FDA will decide the fate of apixaban (Eliquis) by March 17, 2013. The new Prescription Drug User Fee Act (PDUFA) goal date was announced yesterday by the drug’s manufacturers, Pfizer and...
View ArticleRoller Coaster Path To Approval For Eliquis Uncovered By FDA Documents
After the presentation and publication of the pivotal ARISTOTLE trial, the novel anticoagulant apixaban (Eliquis, Pfizer and BristolMyers Squibb) was widely expected to be a blockbuster. But then it...
View Article
More Pages to Explore .....